T. Gleason Shane's most recent trade in InspireMD Inc was a trade of 238,625 Common Stock done . Disclosure was reported to the exchange on Jan. 23, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
InspireMD Inc | T. Gleason Shane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 238,625 | 514,365 (14%) | 6% | 0 | Common Stock | |
InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 91,218 | 183,128 | - | - | Options to purchase common stock (right to buy) | |
InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2023 | 19,290 | 275,740 (7%) | 0% | 0 | Common Stock | |
InspireMD Inc | Shane T. Gleason | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2023 | 6,430 | 91,910 | - | - | Options to purchase common stock (right to buy) | |
InspireMD Inc | Shane T. Gleason | VP Global Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 256,450 | 256,450 (7%) | 7% | 0 | Common Stock | |
InspireMD Inc | Shane T. Gleason | VP Global Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 85,480 | 85,480 | - | - | Options to purchase common stock (right to buy) |